Shanghai Public Health Clinical Center
🇨🇳China
Efficacy and Tolerability of DTG Plus 3TC in HIV Infected Adults With Virologically Suppression and TDF Toxicity
Phase 4
Not yet recruiting
- Conditions
- Interventions
- First Posted Date
- 2022-08-09
- Last Posted Date
- 2022-08-09
- Lead Sponsor
- Shanghai Public Health Clinical Center
- Target Recruit Count
- 100
- Registration Number
- NCT05493969
Functional Cure Study of Anti-PD-L1 Antibody ASC22 in Combination With Chidamide in HIV-infected Patients With Antiviral Suppression
- First Posted Date
- 2021-11-22
- Last Posted Date
- 2022-09-19
- Lead Sponsor
- Shanghai Public Health Clinical Center
- Target Recruit Count
- 15
- Registration Number
- NCT05129189
- Locations
- 🇨🇳
Shanghai Public Health Clinical Center, Shanghai, Shanghai, China
Switching From TDF-based Antiretroviral Therapy Regimens to B/F/TAF in Virally Suppressed Adults With HIV-1 Infection
Phase 4
Active, not recruiting
- Conditions
- Interventions
- First Posted Date
- 2021-11-17
- Last Posted Date
- 2023-12-21
- Lead Sponsor
- Shanghai Public Health Clinical Center
- Target Recruit Count
- 150
- Registration Number
- NCT05122754
- Locations
- 🇨🇳
Xixi hospital of Hangzhou, Hangzhou, Zhejiang, China
🇨🇳Yunnan AIDS Care Center, Kunming, Yunnan, China
🇨🇳Shanghai Public Health Clinical Center, Shanghai, Shanghai, China
Study to Evaluate the Efficacy and Safety of Colchicine Tablets in Patients With COVID-19
Not Applicable
- Conditions
- Interventions
- First Posted Date
- 2021-09-09
- Last Posted Date
- 2021-09-09
- Lead Sponsor
- Shanghai Public Health Clinical Center
- Target Recruit Count
- 60
- Registration Number
- NCT05038449
- Locations
- 🇨🇳
Shanghai Public Health Clinical Center, Shanghai, Shanghai, China
Study of MDW Levels Predicting the Development of Sepsis in Hospitalized HIV-infected Patients and Correlation With Prognosis
- Conditions
- Interventions
- First Posted Date
- 2021-09-08
- Last Posted Date
- 2021-11-30
- Lead Sponsor
- Shanghai Public Health Clinical Center
- Target Recruit Count
- 450
- Registration Number
- NCT05036928
- Locations
- 🇨🇳
Shanghai Public Health Clinical Center, Shanghai, Shanghai, China
Zadaxin and HIV-positive Patients With Immune Reconstitution Disorder
- First Posted Date
- 2021-07-15
- Last Posted Date
- 2023-07-18
- Lead Sponsor
- Shanghai Public Health Clinical Center
- Target Recruit Count
- 20
- Registration Number
- NCT04963712
- Locations
- 🇨🇳
Fudan University, Shanghai, Shanghai, China
Role of Lymphocyte Subsets and Laboratory Measurements in COVID-19 Disease
- Conditions
- First Posted Date
- 2021-03-03
- Last Posted Date
- 2021-03-03
- Lead Sponsor
- Shanghai Public Health Clinical Center
- Target Recruit Count
- 1
- Registration Number
- NCT04779359
TB-LAM in the Diagnosis of TB
Not Applicable
- Conditions
- Interventions
- First Posted Date
- 2020-10-23
- Last Posted Date
- 2020-10-23
- Lead Sponsor
- Shanghai Public Health Clinical Center
- Target Recruit Count
- 400
- Registration Number
- NCT04600232
Efficacy of 400 mg Efavirenz Versus Standard 600 mg Dose in HIV/TB Co-infected Patients
- First Posted Date
- 2020-08-14
- Last Posted Date
- 2020-08-14
- Lead Sponsor
- Shanghai Public Health Clinical Center
- Target Recruit Count
- 80
- Registration Number
- NCT04513379
Euphorbia Kansui and HIV/AIDS Functional Cure
- First Posted Date
- 2020-08-07
- Last Posted Date
- 2020-08-10
- Lead Sponsor
- Shanghai Public Health Clinical Center
- Target Recruit Count
- 12
- Registration Number
- NCT04503928
- Locations
- 🇨🇳
Shanghai,China, Fudan University, Shanghai, China
© Copyright 2024. All Rights Reserved by MedPath